PB1846: ALTERATIONS IN PRIMARY HEMOSTASIS AS ADDITIONAL RISK FACTORS OF BLEEDING IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML): UPDATED PROSPECTIVE ANALYSIS.
Main Authors: | Z. Stupakova, D. Iryna, M. Zoya, S. Anna, O. Karnabeda, U. Melnyk, O. Novosad |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000850236.13859.bd |
Similar Items
-
P590: MODIFICATIONS IN PRIMARY HEMOSTASIS AS ADDITIONAL RISK FACTORS OF BLEEDING IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML): UKRAINIAN PROSPECTIVE STUDY IN A REAL-LIFE COHORT.
by: Zinaida Stupakova, et al.
Published: (2023-08-01) -
Profile of Glasdegib for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML): Evidence to Date
by: Iyer SG, et al.
Published: (2022-08-01) -
PB1842: EARLY DEATH IN NEWLY DIAGNOSED ADULT ACUTE MYELOID LEUKEMIA
by: N. Siala, et al.
Published: (2022-06-01) -
Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect® MDS/AML Disease Registry
by: Daniel A. Pollyea, et al.
Published: (2020-07-01) -
Newly Diagnosed Acute Myeloid Leukemia with Neck Swelling
by: Maha Al-Yahyai, et al.
Published: (2011-11-01)